Jefferies
Tracked across 6 events · 54 articles · First seen Feb 10, 2026 · Last active Apr 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Jefferies is acting as a joint bookrunning manager for Nektar Therapeutics' public offering, indicating its role in facilitating the transaction and earning underwriting fees.
Feb 10, 2026 · 7 articles
Business
Jefferies is serving as a joint book-running manager for the Xenon Pharmaceuticals offering. Jefferies also recently raised its price target for Xenon Pharmaceuticals to $100, citing the potential of azetukalner.
Mar 09, 2026 · 9 articles
Business
Jefferies' chairman of Global TMT investment banking, Ron Eliasek, observed that many public software companies are trading at unsustainable low multiples, suggesting future take-privates or valuation improvements.
Feb 11, 2026 · 7 articles
Tech
Jefferies, an international broker, described the market reaction to AI product launches as 'SaaSpocalypse,' reflecting the analytical perspective on the significant disruption facing the software as a service industry.
Feb 17, 2026 · 14 articles
Business
Jefferies served as financial advisor to KPS Capital Partners in the acquisition of Jennmar.
Mar 11, 2026 · 9 articles
+ 1 more events
View on Dashboard
Ron Eliasek
chairman of Global TMT investment banking
↔
Jefferies
Ron Eliasek is the chairman of Global TMT investment banking at Jefferies.
NEWSDESK
Track Jefferies live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard